TrialClinical rheumatology2021

The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial.

John D Reveille et al.PubMed ↗Publisher ↗

No numbers read from the abstract.